The Health Insurance Portability and Accountability Act of 1996 was enacted by the United States Congress and signed by President Bill Clinton in 1996. It has been known as the KennedyKassebaum Act or Kassebaum-Kennedy Act after two of its leading sponsors. Title I of HIPAA protects health insurance coverage for workers and their families when they change or lose their jobs. Title II of HIPAA, known as the Administrative Simplification (AS) provisions, requires the establishment of national standards for electronic health care transactions and national identifiers for providers, health insurance plans, and employers.
HIPAA Compliance: Protecting your patients health information is more difficult and more important than ever. HIPAA rules have been adopted which pertain to all Protected Health Information (PHI) including paper and electronic, as well as dealing specifically with Electronic Protected Health Information (EPHI).
Envoy Data has gone to great lengths to design-in solutions that are HIPAA compliant, and ready to easily be added to your existing infrastructure and make your company compliant with these government mandates.
The HITECH Act (Health Information Technology for Economic and Clinical Health Act) requires entities covered by the HIPAA to report data breaches, which affect 500 or more persons, to the United States Department of Health and Human Services (U.S.HHS), to the news media, and to the people affected by the data breaches.
- ML Strategies Health Care Preview – Week of December 11thThis week, Republicans will ramp up efforts to pass a tax reform package. We should also get signs that a year-end spending deal is coming together. How things play out this week — both inside and outside the Beltway — will have implications for taxes, health care, and funding the government. For the complete preview, please... […]
- Proposed Medicare Advantage and Part D Regulations for CY 2019 – CMS Takes on the Opioid EpidemicAmericans today are facing an opioid epidemic that stems in part from the misuse of prescription drugs. CMS takes aim at this crisis in its CY 2019 Medicare Advantage and Part D Proposed Rule (Proposed Rules) by setting out a framework for Part D plans to monitor and reduce the potential misuse of frequently abused prescription drugs. (Those... […]
- ML Strategies Weekly Health Care Preview – Week of December 4thFollowing weekend passage of the Senate tax bill, we return this week with Congress needing to pass a government-spending bill. While it’s widely expected that this will be a two-week continuing resolution (CR), giving lawmakers time to hash out a long-term deal, a short-term extension still requires Democratic votes since spending measures can be filibustered... […]
- Fifth Circuit Limits FCA Liability Due to Lack of “Materiality” in Highway Guardrails CaseEarlier this week we released a Health Care Enforcement Advisory about a recent decision from the U.S. Court of Appeals for the Fifth Circuit that may have a significant impact on the element of “materiality” in False Claims Act (FCA) cases. A panel of judges on the Fifth Circuit overturned a district court decision after a jury... […]
- Proposed Medicare Advantage and Part D Regulations for CY 2019 – CMS Tries to Clarify Any Willing Pharmacy RulesMedicare Part D plan sponsors and pharmacies are often confused by the program’s any willing pharmacy (AWP) requirements. Since the inception of the Medicare Part D program, the Centers for Medicare & Medicaid Services (CMS) has required Part D plan sponsors to: (i) have standard terms and conditions that are “reasonable and relevant;” and (ii) allow... […]
- Proposed Medicare Advantage and Part D Regulations for CY 2019 – CMS Takes Aim at Drug PricesThe rising cost of drugs in the U.S. is frequently in the news. So it is not surprising that in its contract year 2019 Proposed Medicare Advantage and Part D Regulations (Proposed Rule), the Centers for Medicare & Medicaid Services (CMS) seeks to address Part D drug prices. CMS proposes making certain changes that might lower drug costs... […]
- ML Strategies December 2017 Legislative PreviewCongress has its work cut out for itself between now and the end of the year. Between addressing the programs that constitute the Health Care Minibus, funding the government, and tax reform, there are also questions related to a market stabilization package (Alexander-Murray), the 340B program, the opioid epidemic, and another hurricane relief package. For the complete... […]
- CMS Releases CY 2019 Proposed Rule for Medicare Advantage and Part DLast Thursday, November 17, 2017, the Centers for Medicare & Medicaid Services (CMS) released its proposed contract year 2019 Medicare Advantage and Part D regulations. The proposed rule is scheduled to be published in the Federal Register on November 28, 2017. The proposed rule focuses on many issues including but not limited to: Implementing certain... […]
- FTC Hosts Workshop on Competition in Prescription Drug MarketsOn Monday, November 13, our colleagues in the Antitrust Section published an alert on the recent FTC workshop, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.” The workshop, which was held on November 8, 2017, began with two keynote addresses from FTC Acting Chairman Maureen Ohlhausen and FDA Commissioner Dr. Scott Gottlieb. Both... […]
- How Eliminating The Medical Expense Deduction Could Increase Medicaid SpendingThe release of the House and Senate GOP tax plan this month has left Washington on edge as it comes to grips with the realities of tax reform. However, the elimination of the medical expense tax deduction in the House Republicans’ tax reform package stands out above the rest as misguided. This elimination would not... […]